Skip to main content
Trials
Sponsors
Conditions
Drugs
Pricing
Trials
Sponsors
Conditions
Drugs
Pricing
Loading search results
Clinical Trials for "David - Yarnitsky, Prof."
6
trials
Share
Relevance
ID
Status
Phase
Title
Sponsor
NCT01721564
Completed
Not Applicable
Bosentan and Pulmonary Endothelial Function
Prof David S Celermajer
ClinicalTrials.gov
NCT01721564
Completed
Not Applicable
Bosentan and Pulmonary Endothelial Function
Prof David S Celermajer
NCT01745263
Completed
Phase 3
DO-HEALTH / Vitamin D3 - Omega3 - Home Exercise - Healthy Ageing and Longevity Trial
Charite University, Berlin, Germany
ClinicalTrials.gov
NCT01745263
Completed
Phase 3
DO-HEALTH / Vitamin D3 - Omega3 - Home Exercise - Healthy Ageing and Longevity T...
Charite University, Berli...
NCT03380442
Unknown
Phase 2
Psilocybin and Depression
Dr. Robin Carthart-Harris and Prof. David Nutt, Imperial College London, UK
ClinicalTrials.gov
NCT03380442
Unknown
Phase 2
Psilocybin and Depression
Dr. Robin Carthart-Harris...
NCT03679533
Completed
Not Applicable
The Impact of Cranberries On the Microbiome and the Brain in Healthy Ageing sTudy (COMBAT)
Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK)
ClinicalTrials.gov
NCT03679533
Completed
Not Applicable
The Impact of Cranberries On the Microbiome and the Brain in Healthy Ageing sTud...
Clinical Research and Tri...
NCT07096973
Recruiting
Cardiac REhabilitation COhort at the Medicine Campus DaVos to invEstigate Recovery
Hochgebirgsklinik Davos
ClinicalTrials.gov
NCT07096973
Recruiting
-
Cardiac REhabilitation COhort at the Medicine Campus DaVos to invEstigate Recove...
Hochgebirgsklinik Davos
NCT02129816
Terminated
Phase 2/3
Bryophyllum Pinnatum Versus Solifenacin Versus Placebo for Overactive Bladder
Dr. med. David Scheiner
ClinicalTrials.gov
NCT02129816
Terminated
Phase 2/3
Bryophyllum Pinnatum Versus Solifenacin Versus Placebo for Overactive Bladder
Dr. med. David Scheiner
Result Breakdown
Status
Completed
3 (50%)
Unknown
1 (17%)
Recruiting
1 (17%)
Terminated
1 (17%)
Phase
not_applicable
2 (33%)
Phase 3
1 (17%)
Phase 2
1 (17%)
Not Specified
1 (17%)
Phase 2/3
1 (17%)
Top Conditions
Pulmonary Arterial Hypertension
1 (17%)
Improve Healthy Ageing in Seniors; Prevent Disease at Older Age
1 (17%)
Severe Depression
1 (17%)
Show 7 more
Top Sponsors
University of Zurich
2 (33%)
Prof David S Celermajer
1 (17%)
Charite University, Berlin, Germany
1 (17%)
Show 7 more
Start your search
Search over 500,000 clinical trials worldwide
Search
Expert
Popular:
Cancer
Diabetes
Alzheimer
COVID-19
Heart Disease